poisar

News

Current market catalysts

Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.

Latest Coverage

Latest Headlines

30 headlines

  1. The Motley FoolJames Halley

    Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now

    While Pfizer offers a higher dividend yield of 6.1%, AbbVie is positioned as the superior long-term dividend stock. AbbVie has demonstrated stronger revenue growth (138% over a decade vs. Pfizer's 18%), is a Dividend King with 53 consecutive years of dividend increases, and has successfully navigated the loss of Humira exclusivity through home-grown replacements Skyrizi and Rinvoq. In contrast, Pfizer faces significant patent cliff exposure between 2026-2028 with $17-18 billion in annual revenue at risk from generic competition.

  2. SEC EDGARSEC EDGAR

    8-K filing — Federal Home Loan Bank of Boston

    Filed: 2026-09-08 AccNo: 0001331463-26-000174 Size: 164 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

  3. SEC EDGARSEC EDGAR

    8-K filing — FRANKLIN ELECTRIC CO INC (FELE)

    Filed: 2026-09-08 AccNo: 0000038725-26-000062 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Source
Source-attributed market-news archive
Observed
Checked
Cadence
Continuous captured-news feed
Status
fresh